Public Policy Office, amfAR, Foundation for AIDS Research, Washington, DC, USA.
GATE, New York, USA.
J Int AIDS Soc. 2021 Nov;24(11):e25837. doi: 10.1002/jia2.25837.
Trans people are disproportionately impacted by HIV yet have not been adequately prioritized in national HIV responses or policy documents. This review aims to understand the extent of meaningful inclusion of trans people in national strategic plans (NSPs) for HIV/AIDS as an essential step in ensuring that HIV policy aligns with epidemiologic data, and trans-specific programming is funded, implemented and sustained.
HIV NSPs from 60 countries, across five global regions, were assessed for the level of inclusion of trans populations between January and March 2021. The most recently available NSP for each country, published after 2011, was obtained through publicly accessible online sources or through researcher networks. Data were manually extracted from NSPs using a framework of indicators focusing on trans inclusion in these five major sections of NSPs: (1) narratives; (2) epidemiological data; (3) monitoring and evaluation (M&E) indicators and targets; (4) activities; and (5) budgets.
Within all reviewed NSPs, 65.0% (39/60) mentioned trans people in at least one of the five key sections but only 8.3% (5/60) included trans people in all five key sections. Trans people were more commonly mentioned in the background/narratives of NSPs (61.7%, 37/60) but less commonly included NSP activities (38.3%, 23/60), in M&E indicators and targets (23.7%, 14/60), in epidemiological data (20.0% 12/60), and in NSP budgets (13.3%, 8/60). Countries in the Asia and Pacific region most frequently included trans people in all five key sections (38%, 5/13), while no countries in Eastern and Southern Africa included trans people in all NSP sections.
This analysis finds substantial gaps in the inclusion of trans populations in NSPs globally. Results highlight the pressing need for states, technical partners, and international funders to engage with trans communities to improve trans-inclusion in all key sections of NSPs. Trans inclusion in NSPs is an essential step towards reaching the populations most at risk of HIV and ultimately achieving country-level epidemic control.
跨性别者受 HIV 的影响不成比例,但在国家 HIV 应对措施或政策文件中未得到足够重视。本研究旨在了解将跨性别者纳入国家艾滋病毒/艾滋病战略计划(NSP)的程度,这是确保 HIV 政策符合流行病学数据以及为特定于跨性别者的规划提供资金、实施和维持的重要步骤。
2021 年 1 月至 3 月,评估了来自五个全球区域的 60 个国家的 HIV NSP,以了解跨性别者群体在多大程度上被纳入其中。通过公开获取的在线资源或研究人员网络,获取每个国家最新的、于 2011 年后发布的 NSP。使用关注 NSP 中以下五个主要部分中跨性别者纳入情况的指标框架,从 NSP 中手动提取数据:(1)叙述;(2)流行病学数据;(3)监测和评估(M&E)指标和目标;(4)活动;和(5)预算。
在所有审查的 NSP 中,65.0%(39/60)在至少一个关键部分中提到了跨性别者,但只有 8.3%(5/60)在所有五个关键部分中都包括了跨性别者。跨性别者在 NSP 的背景/叙述中更为常见(61.7%,37/60),但在 NSP 活动中较少提及(38.3%,23/60),在 M&E 指标和目标中(23.7%,14/60),在流行病学数据中(20.0%,12/60)和 NSP 预算中(13.3%,8/60)。亚太地区的国家最常将跨性别者纳入所有五个关键部分(38%,5/13),而东部和南部非洲没有一个国家将跨性别者纳入所有 NSP 部分。
本分析发现全球范围内 NSP 中纳入跨性别者的情况存在很大差距。结果突出表明,各国、技术合作伙伴和国际资助者迫切需要与跨性别者社区合作,以改善 NSP 所有关键部分对跨性别者的包容性。将跨性别者纳入 NSP 是实现艾滋病毒高危人群并最终实现国家一级疫情控制的重要步骤。